Clinical Trial Update: Phase 1/1b Study of TLC-6740 in Healthy Subjects and Subjects With Obesity, With or Without Diabetes [Phase 1]

View source ↗

Summary

A Phase 1/1b trial is evaluating the safety and pharmacokinetics of TLC-6740 in healthy subjects and in individuals with obesity, with or without Type 2 diabete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 2 Diabetes Mellitus

Drugs mentioned

• TLC-6740

Snippet

Sponsor: OrsoBio, Inc | Conditions: Healthy Subjects, Obesity | Phase 1 | Status: RECRUITING